Moleculin Biotech, Inc.
Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment …
Biotechnology
US, Houston [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Moleculin Biotech, Inc. has no acquisition track records yet.
M&A Deals · History
Moleculin Biotech, Inc. has no acquisition track records yet.